Eyconis
CompanyUnited States
Eyconis develops one asset, in phase 1 (EYC-0305 in neovascular (wet) age-related macular degeneration). Mostly other; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 1
- 1
- Trial
- 1
- Signal
Pipeline
1Phase 1, Other, neovascular (wet) age-related macular degeneration
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals2